What is NovoCure's earnings yield?

NovoCure (NVCR) reported earnings yield of -14% in Q1 2026.

How has NovoCure's earnings yield changed year-over-year?

NovoCure's earnings yield decreased by 66.4% year-over-year, from -8.4% to -14%.

What is the long-term trend for NovoCure's earnings yield?

Over 5 years (2020 to 2025), NovoCure's earnings yield has grown at a 143.3% compound annual growth rate (CAGR), from 0.1% to -9.4%.

What does earnings yield mean?

Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.

NovoCure NVCR Earnings yield

Earnings yield at other companies

Boston ScientificBSX

3.8%+2.5pp

MedtronicMDT

4.6%+0.3pp

Iovance Biotherapeutics, Inc.IOVA

-24.5%-5.5pp

Nuvation BioNUVB

-9.8%-4.6pp

Vir Biotechnology, Inc.VIR

-30.9%-10.6pp

Syndax PharmaceuticalsSNDX

-11.8%-4.5pp

Other financials

Income statement

See full

Revenue$174.1M+12.3%

Gross profit$135.1M+16.0%

Operating income-$67.4M-78.1%

Net income-$71.1M-107%

EPS (diluted)-$0.62-100%

Balance sheet

See full

Cash & equivalents$87.5M-31.2%

Total debt$39.5M-2.1%

Total equity$330.7M-8.6%

Total assets$787.9M-36.9%

Cash flow

See full

Operating cash flow-$13.5M+62.1%

CapEx$5.2M-51.4%

Free cash flow-$18.7M+59.7%

Valuation

See full

Market cap$1.7B-36.7%

Profitability

See full

Gross margin75.2%-2.0pp

Operating margin-27.2%+0.4pp

Net margin-25.7%-0.7pp

FCF margin-7.1%-2.0pp

Returns & leverage

See full

Return on equity-50%+5.4pp

Debt / equity0.1×0.0×

Current ratio2.9×+1.4×

Where this comes from

Calculated from NovoCure’s reported figures.

net income/market cap=-14%

Based on trailing twelve months.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovoCure's earnings yield?: NovoCure (NVCR) reported earnings yield of -14% in Q1 2026.
How has NovoCure's earnings yield changed year-over-year?: NovoCure's earnings yield decreased by 66.4% year-over-year, from -8.4% to -14%.
What is the long-term trend for NovoCure's earnings yield?: Over 5 years (2020 to 2025), NovoCure's earnings yield has grown at a 143.3% compound annual growth rate (CAGR), from 0.1% to -9.4%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.